accountFRANKFURT -(Dow Jones)- German pharmaceutical and chemical company Bayer AG ( BAY.XE) said Thursday it will appeal a decision by the U.K.'s healthcare cost regulator not to recommend the company's Nexavar for liver cancer treatment. The...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Bayer To Appeal NICE Decision On Liver Cancer Drug Nexavar
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account